Literature DB >> 15699046

Interaction between LRP5 and Frat1 mediates the activation of the Wnt canonical pathway.

Eric Hay1, Chi Faucheu, Isabelle Suc-Royer, Robert Touitou, Veronique Stiot, Béatrice Vayssière, Roland Baron, Sergio Roman-Roman, Georges Rawadi.   

Abstract

Low density lipoprotein receptor-related protein 5 (LRP5) has been identified as a Wnt co-receptor involved in the activation of the beta-catenin signaling pathway. To improve our understanding of the molecular mechanisms by which LRP5 triggers the canonical Wnt signaling cascade, we have screened for potential partners of LRP5 using the yeast two-hybrid system and identified Frat1 as a protein interacting with the cytoplasmic domain of LRP5. We demonstrate here that LRP5/Frat1 interaction is involved in beta-catenin nuclear translocation and TCF-1 transcriptional activation. The addition of Wnt3a or overexpression of constitutively active truncated LRP5 (LRP5C) induces Frat1 recruitment to the cell membrane. Overexpression of a dominant negative form of disheveled (Dvl) shows that this protein positively affects LRP5/Frat1 interaction. Furthermore, the fact that dominant negative Dvl does not interfere with LRP5C/Frat1 interaction can explain how LRP5C is capable of acting independently of this major Wnt signaling player. Axin, which has been shown to interact with LRP5 and to be recruited to the membrane through this interaction, was found to co-immunoprecipitate with Frat1 and LRP5. We propose that recruitment of Axin and Frat1 to the membrane by LRP5 leads to both Axin degradation and Frat1-mediated inhibition of glycogen synthase kinase-3. As a consequence, beta-catenin is no longer bound to Axin or phosphorylated by glycogen synthase kinase-3, resulting in TCF-1 activation.

Entities:  

Mesh:

Substances:

Year:  2005        PMID: 15699046     DOI: 10.1074/jbc.M411999200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  30 in total

Review 1.  Regulatory pathways revealing new approaches to the development of anabolic drugs for osteoporosis.

Authors:  T J Martin; N A Sims; K W Ng
Journal:  Osteoporos Int       Date:  2008-03-13       Impact factor: 4.507

Review 2.  Signaling and transcriptional regulation in osteoblast commitment and differentiation.

Authors:  Wei Huang; Shuying Yang; Jianzhong Shao; Yi-Ping Li
Journal:  Front Biosci       Date:  2007-05-01

Review 3.  Signaling networks that control the lineage commitment and differentiation of bone cells.

Authors:  Carrie S Soltanoff; Shuying Yang; Wei Chen; Yi-Ping Li
Journal:  Crit Rev Eukaryot Gene Expr       Date:  2009       Impact factor: 1.807

4.  Overexpression of Frat1 correlates with malignant phenotype and advanced stage in human non-small cell lung cancer.

Authors:  Yong Zhang; Juan-Han Yu; Xu-Yong Lin; Yuan Miao; Yang Han; Chui-Feng Fan; Xin-Jun Dong; Shun-Dong Dai; En-Hua Wang
Journal:  Virchows Arch       Date:  2011-08-05       Impact factor: 4.064

5.  Wnt/β-catenin signaling mediates osteoblast differentiation triggered by peptide-induced α5β1 integrin priming in mesenchymal skeletal cells.

Authors:  Zuzana Saidak; Carole Le Henaff; Sofia Azzi; Caroline Marty; Sophie Da Nascimento; Pascal Sonnet; Pierre J Marie
Journal:  J Biol Chem       Date:  2015-01-28       Impact factor: 5.157

6.  Stability elements in the LRP6 cytoplasmic tail confer efficient signalling upon DIX-dependent polymerization.

Authors:  Ciara Metcalfe; Carolina Mendoza-Topaz; Juliusz Mieszczanek; Mariann Bienz
Journal:  J Cell Sci       Date:  2010-04-13       Impact factor: 5.285

7.  Parathyroid hormone receptor directly interacts with dishevelled to regulate beta-Catenin signaling and osteoclastogenesis.

Authors:  Guillermo Romero; W Bruce Sneddon; Yanmei Yang; David Wheeler; Harry C Blair; Peter A Friedman
Journal:  J Biol Chem       Date:  2010-03-08       Impact factor: 5.157

8.  Basic fibroblast growth factor inhibits osteogenic differentiation of stem cells from human exfoliated deciduous teeth through ERK signaling.

Authors:  B Li; C Qu; C Chen; Y Liu; K Akiyama; R Yang; F Chen; Y Zhao; S Shi
Journal:  Oral Dis       Date:  2011-12-12       Impact factor: 3.511

9.  N-cadherin interacts with axin and LRP5 to negatively regulate Wnt/beta-catenin signaling, osteoblast function, and bone formation.

Authors:  Eric Haÿ; Emmanuel Laplantine; Valérie Geoffroy; Monique Frain; Thomas Kohler; Ralph Müller; Pierre J Marie
Journal:  Mol Cell Biol       Date:  2008-12-15       Impact factor: 4.272

10.  Uncovering molecular biomarkers that correlate cognitive decline with the changes of hippocampus' gene expression profiles in Alzheimer's disease.

Authors:  Martín Gómez Ravetti; Osvaldo A Rosso; Regina Berretta; Pablo Moscato
Journal:  PLoS One       Date:  2010-04-13       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.